Project number: VPP-COVID-2020 / 1-0014
Type: National research program “Mitigation of Covid-19 effects”
Duration of the project: 01.07.2020 - 31.12.2020
Project manager: Latvian Biomedical Research and Study Center (BMC), Dr. biol. Kaspars Tārs
Cooperation partners: Latvian Institute of Organic Synthesis; Institute of Solid State Physics, University of Latvia (ISSP UL); Riga Technical University; University of Latvia
Project manager from ISSPUL: Dr.sc.ing Gatis Mozolevskis
Total funding: EUR 500 000
ISSP UL funding: EUR 48 809
Project summary:
To develop new vaccine candidates and small molecule drug leader compounds against coronaviruses, especially COVID-19 and its complications. The goal of the project is development of a vaccine candidate, development of new small molecule leader compounds and re-profiling of existing drugs to reduce COVID-19 complications.
Tasks of ISSP UL:
In collaboration with the BMC, to develop lung-on-chip device, which will allow to study of SARS-CoV-2 infection processes. The device will be fabricated from PDMS and protocols will be developed to fabricate the devices from alternative materials.